头颈部腺样囊性癌术后IMRT联合三叉神经通路勾画的疗效分析
BACKGROUND: Head and neck adenoid cystic carcinoma (HN-ACC) is a rare, aggressive malignancy prone to perineural invasion, making treatment challenging.…
要点
- 术后IMRT联合三叉神经通路勾画,5年LRRFS达91.7%。
- 该靶区勾画协议可能为优化HN-ACC放疗策略提供依据。
核心结论
- 采用优先沿三叉神经通路勾画靶区的机构协议行术后IMRT,HN-ACC患者显示出良好的局部区域控制和生存结局。
主要发现
- 5年LRRFS、PFS、DMFS和OS分别为91.7%、63.0%、67.1%和91.3%。
关键数值与推荐
- 预防性覆盖三叉神经分支及颈部淋巴结照射基于临床/病理评估。
- 主要终点为5年局部区域无复发生存率,次要终点包括PFS、DMFS和OS。
临床怎么用
- 术后IMRT靶区勾画可优先沿三叉神经通路进行,以改善HN-ACC的局部区域控制。
- 该机构协议可为放射肿瘤科医生优化HN-ACC的IMRT策略提供参考。
局限性
- 本研究为回顾性设计,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck adenoid cystic carcinoma (HN-ACC) is a rare, aggressive malignancy prone to perineural invasion, making treatment challenging. This study evaluates the outcomes of postoperative intensity-modulated radiation therapy (IMRT) for HN-ACC to guide radiation target delineation, optimizing radiation planning and improving patient outcomes. PATIENTS AND METHODS: A retrospective review of postoperative IMRT outcomes in HN-ACC patients from January 2015 to December 2022 was conducted. Prophylactic coverage of trigeminal nerve branches in the radiation field and cervical nodal irradiation was based on clinical/pathological assessments. The primary endpoint was 5-year locoregional recurrence-free survival (LRRFS), with secondary endpoints including progression-free survival (PFS), distant metastasis-free survival (DMFS), and overall survival (OS). RESULTS: A total of 328 patients were followed for a median of 61.1 months. The 5-year LRRFS, PFS, DMFS, and OS rates were 91.7 %, 63.0 %, 67.1 %, and 91.3 %, respectively. Thirty patients experienced locoregional recurrence, comprising 19 local recurrences, 6 regional recurrences, and 5 combined local and regional recurrences. Eleven patients had recurrence involving trigeminal nerve branches (8 in-field, 3 marginal). CONCLUSIONS: Postoperative IMRT for HN-ACC, utilizing our institutional target delineation protocol that prioritizes delineating the target along the trigeminal nerve pathway, suggests favorable locoregional control and survival outcomes. These results suggest evidence-based insights that could inform clinical practice and support radiation oncologists in optimizing IMRT strategies for HN-ACC.
引用
- Jiang W, Xiao Y, Hu H, et al. Postoperative Intensity-Modulated radiotherapy with trigeminal nerve pathway delineation for head and neck adenoid cystic carcinoma. Radiother Oncol. 2025. PMID: 41027510. doi:10.1016/j.radonc.2025.111174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。